ArticleGraefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie2018
Current trends among pediatric ophthalmologists to decrease myopia progression-an international perspective.
Article in Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 26 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
26 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Benefits and risks of orthokeratology treatment: a systematic review and meta-analysis.International ophthalmology · 2024Pooled it
- Myopia progression after cessation of atropine in children: a systematic review and meta-analysis.Frontiers in pharmacology · 2024Pooled it
- Efficacy Comparison of Repeated Low-Level Red Light and Low-Dose Atropine for Myopia Control: A Randomized Controlled Trial.Translational vision science & technology · 2022Trial
- A multicenter Spanish study of atropine 0.01% in childhood myopia progression.Scientific reports · 2021Trial
- Incidence and Risk Factors of Refractive Error in Children in Spain: CISViT Project.Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists) · 2026Article
- Prevalence of refractive errors among medical and applied medical sciences students, University of Bisha, Saudi Arabia.Journal of family medicine and primary care · 2025Article
- Factors influencing shared decision-making and decision regret in parents of children undergoing myopia control within one year.BMC ophthalmology · 2025Article
- How Have Animal Models Increased our Understanding of Human Myopia?Investigative ophthalmology & visual science · 2025Review
- Does 0.01% atropine have a place as a myopia control therapy?Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists) · 2025Article
- Juvenile-onset myopia-who to treat and how to evaluate success.Eye (London, England) · 2024Review
- Can Google Help Your Nearsightedness? A Google Trend Analysis of Public Interest in Myopic Progression.Clinical ophthalmology (Auckland, N.Z.) · 2024Article
- Bibliometric analysis of hotspots and trends of global myopia research.International journal of ophthalmology · 2024Article
- Age-related results over 2 years of the multicenter Spanish study of atropine 0.01% in childhood myopia progression.Scientific reports · 2023Article
- Low-Dose 0.01% Atropine Eye Drops vs Placebo for Myopia Control: A Randomized Clinical Trial.JAMA ophthalmology · 2023Article
- Myopia progression risk assessment score (MPRAS): a promising new tool for risk stratification.Scientific reports · 2023Article
- Decision Behavior and Influential Factors of Spectacle Prescription for Schoolchildren in Taiwan.Clinical optometry · 2023Article
- The impact of the first peak of the COVID-19 pandemic on childhood myopia control practice patterns among ophthalmologists-an international pediatric ophthalmology and strabismus council global perspective.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2023Article
- Characteristics of responders to atropine 0.01% as treatment in Asian myopic children.Scientific reports · 2022Observational
- The impact of spectacle lenses for myopia control on visual functions.Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians (Optometrists) · 2021Article
- Stepwise low concentration atropine for myopic control: a 10-year cohort study.Scientific reports · 2021Article
Corrections and comments
- Erratum issued
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo explore what the current worldwide preferred practice patterns of pediatric ophthalmologists are to decrease myopia progression among their patients.
methodsA questionnaire was sent to all members of supranational and national pediatric ophthalmology and strabismus societies.
resultsThe questionnaire was fully completed by most respondents 90.10% (847 of 940 responses). Fifty-seven percent (457) routinely treat to decrease myopia progression. The most common parameter to initiate treatment was a myopic increase of 1 diopter/year or more (74.8%, 246). Seventy percent (345) prescribed eye drops. Atropine 0.01% was the most popular (63.4%, 277) followed by atropine 1% (10.9%, 48) and atropine 0.5% (8.9%, 39). Eighty-six percent (394) of the respondents advised to spend more time outdoors, to reduce the amount of time viewing screens (60.2%, 277), and cutback the use of smart phones (63.9%, 294).
conclusionsMost pediatric ophthalmologists treat to decrease myopia. They employ a wide variety of means to decrease myopia progression. Atropine 0.01% is the most popular and safe modality used similarly to recent reports. However, there is no consensus when treatment should be initiated. Further prospective studies are needed to elucidate the best timing to start treatment and the applicability of recent studies in the Asian population to other ethnic groups. This will improve the ability to update pediatric ophthalmologist with evidenced-based treatment options to counter the myopia epidemic.
Indexed as
Identifiers
30074069What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.